Sage Therapeutics, Inc.（SAGE）内部人交易：高管与董事近期交易
过去 18 个月，共有 7 位内部人为 Sage Therapeutics, Inc.（SAGE）报告了 13 笔 Form 4 交易（最近一笔 2025-07-31）。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2025-07-31 | Benecchi Christopher | Chief Operating Officer | 卖出 | 36,375 | $0 |
| 2025-07-31 | Barrett Elizabeth A. | 董事 | 卖出 | 3,000 | $0 |
| 2025-07-31 | Shiferman Gregory L. | Senior Vice President, General Counsel and Secretary | 卖出 | 7,215 | $0 |
| 2025-07-31 | Shiferman Gregory L. | Senior Vice President, General Counsel and Secretary | 卖出 | 23,735 | $0 |
| 2025-07-31 | FRATES JAMES M | 董事 | 卖出 | 2,845 | $0 |
| 2025-07-31 | Benecchi Christopher | Chief Operating Officer | 卖出 | 28,053 | $0 |
| 2025-07-31 | Golumbeski George | 董事 | 卖出 | 8,000 | $0 |
| 2025-07-31 | Greene Barry E | President and CEO | 卖出 | 46,940 | $0 |
| 2025-07-31 | Greene Barry E | President and CEO | 卖出 | 53,229 | $0 |
| 2025-07-31 | Quirk Michael C. | Chief Scientific Officer and Interim Head of R&D | 卖出 | 24,999 | $0 |
| 2025-07-31 | Quirk Michael C. | Chief Scientific Officer and Interim Head of R&D | 卖出 | 7,962 | $0 |
| 2025-06-26 | Shiferman Gregory L. | Senior Vice President, General Counsel and Secretary | 卖出 | 79 | $728 |
| 2025-06-26 | Quirk Michael C. | Chief Scientific Officer and Interim Head of R&D | 卖出 | 113 | $1,042 |
来源：SEC Form 4 申报文件 · 截至 2025-07-31